Will Abbvie Outsmart Biosimilars, And Can Clovis Win The Parp Race?

AbbVie, Inc. (NYSE: ABBV), Regeneron Pharmaceuticals (NASDAQ: REGN), and Clovis Oncology (NASDAQ: CLVS) all have at least one thing in common: All three are subjects of this week's Industry Focus: Healthcare!In this edition, host Kristine Harjes is joined by contributor Todd Campbell. Among other topics, the two discuss:Are any of these top stocks you should be buying now?

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News